These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37224929)

  • 1. Baicalin/ambroxol hydrochloride combined dry powder inhalation formulation targeting lung delivery for treatment of idiopathic pulmonary fibrosis: Fabrication, characterization, pharmacokinetics, and pharmacodynamics.
    Qi D; Jia B; Peng H; He J; Pi J; Guo P; Zhang Y; Deng X; Li J; Liu Z
    Eur J Pharm Biopharm; 2023 Jul; 188():243-253. PubMed ID: 37224929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Customizable resveratrol spray-dried micro-composites for inhalation as a promising contender for treatment of idiopathic pulmonary fibrosis.
    Ahmed S; Mansour M; Ishak RAH; Mortada ND
    Int J Pharm; 2023 Jul; 642():123117. PubMed ID: 37315636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of formulation and preparation process on ambroxol hydrochloride dry powder inhalation characteristics and aerosolization properties.
    Ren Y; Yu C; Meng K; Tang X
    Drug Dev Ind Pharm; 2008 Sep; 34(9):984-91. PubMed ID: 18800258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary selectivity and local pharmacokinetics of ambroxol hydrochloride dry powder inhalation in rat.
    Ren YC; Wang L; He HB; Tang X
    J Pharm Sci; 2009 May; 98(5):1797-803. PubMed ID: 18837427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repurposing ebselen as an inhalable dry powder to treat respiratory tract infections.
    Saha T; Lyons N; Yue Yung DB; Quiñones-Mateu ME; Pletzer D; Das SC
    Eur J Pharm Biopharm; 2024 Feb; 195():114170. PubMed ID: 38128743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physicochemical stability and aerosolization performance of dry powder inhalation system containing ciprofloxacin hydrochloride.
    Karimi K; Katona G; Csóka I; Ambrus R
    J Pharm Biomed Anal; 2018 Jan; 148():73-79. PubMed ID: 28965047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spray drying siRNA-lipid nanoparticles for dry powder pulmonary delivery.
    Zimmermann CM; Baldassi D; Chan K; Adams NBP; Neumann A; Porras-Gonzalez DL; Wei X; Kneidinger N; Stoleriu MG; Burgstaller G; Witzigmann D; Luciani P; Merkel OM
    J Control Release; 2022 Nov; 351():137-150. PubMed ID: 36126785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-spray-dried poly-L-lysine with L-leucine as dry powder inhalations for the treatment of pulmonary infection: Moisture-resistance and desirable aerosolization performance.
    Zhang X; Zhou Y; Wang G; Zhao Z; Jiang Z; Cui Y; Yue X; Huang Z; Huang Y; Pan X; Wu C
    Int J Pharm; 2022 Aug; 624():122011. PubMed ID: 35820517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cepharanthine Dry Powder Inhaler for the Treatment of Acute Lung Injury.
    Liang D; Wang W; Chen G; Li J; Dou G; Gan H; Han P; Du L; Gu R
    Molecules; 2023 May; 28(11):. PubMed ID: 37298919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of l-Carnitine and l-Carnitine HCL salt for targeted lung treatment of pulmonary hypertension (PH) as inhalation aerosols: Design, comprehensive characterization, in vitro 2D/3D cell cultures, and in vivo MCT-Rat model of PH.
    Acosta MF; Muralidhran P; Abrahamson MD; Grijalva CL; Carver M; Tang H; Klinger C; Fineman JR; Black SM; Mansour HM
    Pulm Pharmacol Ther; 2020 Dec; 65():101998. PubMed ID: 33556627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computationally efficient analysis of particle transport and deposition in a human whole-lung-airway model. Part II: Dry powder inhaler application.
    Kolanjiyil AV; Kleinstreuer C; Sadikot RT
    Comput Biol Med; 2017 May; 84():247-253. PubMed ID: 27836120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Powder, capsule and device: An imperative ménage à trois for respirable dry powders.
    Schoubben A; Blasi P; Giontella A; Giovagnoli S; Ricci M
    Int J Pharm; 2015 Oct; 494(1):40-8. PubMed ID: 26255220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried microparticulate/nanoparticulate antibiotic dry powders of tobramycin and azithromycin for pulmonary inhalation aerosol delivery.
    Li X; Vogt FG; Hayes D; Mansour HM
    Eur J Pharm Sci; 2014 Feb; 52():191-205. PubMed ID: 24215736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and evaluation of sustained release pirfenidone-loaded microsphere dry powder inhalation for treatment of idiopathic pulmonary fibrosis.
    Bao S; Zou Y; Firempong CK; Feng Y; Yu Y; Wang Y; Dai H; Mo W; Sun C; Liu H
    Eur J Pharm Sci; 2023 Sep; 188():106509. PubMed ID: 37356463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled mucoactive particles with tailored architecture for enhanced aerodynamicity, stability and efficacy.
    Lee SH; Heng D; Teo JWP; Toh FKY; Tan RBH
    Int J Pharm; 2019 Dec; 572():118740. PubMed ID: 31648015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and physicochemical characterization of advanced spray-dried tacrolimus multifunctional particles for inhalation.
    Wu X; Hayes D; Zwischenberger JB; Kuhn RJ; Mansour HM
    Drug Des Devel Ther; 2013; 7():59-72. PubMed ID: 23403805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried cyclosporine A multifunctional particles for dry powder inhalation aerosol delivery.
    Wu X; Zhang W; Hayes D; Mansour HM
    Int J Nanomedicine; 2013; 8():1269-83. PubMed ID: 23569375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A facile one-step jet-milling approach for the preparation of proliposomal dry powder for inhalation as effective delivery system for anti-TB therapeutics.
    Srichana T; Eze FN; Thawithong E
    Drug Dev Ind Pharm; 2022 Oct; 48(10):528-538. PubMed ID: 36214588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a Carrier Free Dry Powder Inhalation Formulation of Ketotifen for Pulmonary Drug Delivery.
    Azari F; Ghanbarzadeh S; Safdari R; Yaqoubi S; Adibkia K; Hamishehkar H
    Drug Res (Stuttg); 2020 Jan; 70(1):26-32. PubMed ID: 31533157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvianolic acid B dry powder inhaler for the treatment of idiopathic pulmonary fibrosis.
    Lu P; Li J; Liu C; Yang J; Peng H; Xue Z; Liu Z
    Asian J Pharm Sci; 2022 May; 17(3):447-461. PubMed ID: 35782322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.